| REVIEW ARTICLE |
|
| Year : 2021 | Volume
: 9
| Issue : 1 | Page : 29-37 |
|
|
What's new in COVID-19?
Umar M M A Shareef, Vinod Kumar, Vasantha Kamath
Department of General Medicine, MVJ Medical College and Research Hospital, Bengaluru Rural, Karnataka, India
Correspondence Address:
Dr. Vasantha Kamath
Professor, Department of General Medicine, M.V.J Medical College and Research Hospital, Dandupalya, national Highway 4, 30th Km Milestone Kolathur P.O, Hoskote, Karnataka - 562 114
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ajim.ajim_63_20
|
|
|
COVID-19 has affected over 57,410,025 people and killed more than 1,368,848 of those affected in 220 countries as on November 20, 2020. Community-acquired coronaviruses are ubiquitous with a male preponderance. Unlike Western nations, majority of the cases in India are in the age group of 31–50 years, and the mortality rate is around 1.46%. The possible modes of transmission for severe acute respiratory syndrome coronavirus 2 include droplet, airborne, fomite, fecal-oral, bloodborne, mother-to-child, and animal-to-human transmission as per the World Health Organization. Apart from the known symptoms of influenza-like illness, COVID also presents with cutaneous, hematological, gastrointestinal, and neurological manifestations. In the absence of dedicated cures, until there is a hope of appropriate and effective vaccine development, the novel coronavirus will be a challenge to the existence of humanity.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
